# Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion

> **NCT05693727** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Pleural Effusion, Malignant

## Interventions

- **DIAGNOSTIC_TEST:** pleural markers

## Key facts

- **NCT ID:** NCT05693727
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05693727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05693727, "Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05693727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*